RESEARCH-USE BIOSIMILAR ANTIBODY
Lampalizumab
Antibody fragment · IgG1
Lampalizumab (RG 7417) is a humanised monoclonal antibody targeting complement Factor D in the alternative complement pathway. Lampalizumab binds an exosite and sterically blocks Factor B access to the active site. Lampalizumab can be used for age-related macular degeneration (AMD) research.
TARGETCFD
YAntibody fragment
CATALOGSC-BS-458
CATALOG NUMBERSC-BS-458
MOLECULAR WEIGHTApprox. 143.8 kDa
PRODUCT FORMATAntibody fragment
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Lampalizumab (RG 7417) is a humanised monoclonal antibody targeting complement Factor D in the alternative complement pathway. Lampalizumab binds an exosite and sterically blocks Factor B access to the active site. Lampalizumab can be used for age-related macular degeneration (AMD) research.
Lampalizumab is a recombinant research-use antibody directed against CFD.